Subsequent anti‐myeloma therapy after maturation antigen ( BCMA ) chimeric antigen receptor ( CAR )‐T cell ( HDS269B ) treatment in patients with relapsed/refractory multiple myeloma
Journal article published in 2022 by
Dongjian Chen,
Xiaoxiang Wang,
Zhi Chen 
,
Songfu Jiang,
Hua Jiang,
Weijun Fu,
Fang Xiang,
Xuedong Sun,
Juan Du
,
Songfu Jiang,
Hua Jiang,
Weijun Fu,
Fang Xiang,
Xuedong Sun,
Juan Du
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 